) [153]. this process is at the moment not scalable because it relies on highly-priced startup substrates that may be applied to produce psilocybin in more cost-effective chemical synthesis methodologies. A methodology for de novo creation of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae, Psilocybin (4-phosphoryloxy-N,N-dimethy… Read More